Cytoplasmic sensing of viral double-stranded RNA and activation of innate immunity by RIG-I-like receptors

Innate Immune Regulation and Cancer Immunotherapy

Volumn , Issue , 2012, Pages 51-60

  Yoneyama, Mitsutoshi ^a,b   Fujita, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955339498     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/9781441999146_5     Document Type: Chapter

References (57)

1. Ablasser A, Bauernfeind F, Hartmann G et al (2009) RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase IlI-transcribed RNA intermediate. Nat Immunol 10(10): 1065-1072.
2. Arimoto K, Takahashi H, Hishiki T et al (2007) Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A 104:7500-7505.
3. Balachandran S, Thomas E, Barber GN (2004) A FADD-dependent innate immune mechanism in mammalian cells. Nature 432:401-405.
4. Besch R, Poeck H, Hohenauer T et al (2009) Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 119:2399-2411.
5. Chiu YH, Macmillan JB, Chen ZJ (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576-591.
6. Cui S, Eisenacher K, Kirchhofer A et al (2008) The C-terminal regulatory domain is the RNA 5’-triphosphate sensor of RIG-I. Mol Cell 29:169-179.
7. Diao F, Li S, Tian Y et al (2007) Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci USA 104:11706-1171.
8. Fredericksen BL, Keller BC, Fornek J et al (2008) Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1.J Virol 82:609-616.
9. Friedman CS, O’Donnell MA, Legarda-Addison D et al (2008) The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9:930-936.
10. Gack MU, Shin YC, Joo CH et al (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
11. Gao D, Yang YK, Wang RP et al (2009) REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 4:e5760.
12. Hornung V, Ellegast J, Kim S et al (2006) 5’-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
13. Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678.
14. Jounai N, Takeshita F, Kobiyama K et al (2007) The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 104:14050-14055.
15. Kato H, Sato S, Yoneyama M et al (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28.
16. Kato H, Takeuchi O, Sato S et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
17. Kato H, Takeuchi O, Mikamo-Satoh E et al (2008) Length-dependent recognition of doublestranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601-1610.
18. Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1-20.
19. Kawai T, Takahashi K, Sato S et al (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988.
20. Kayagaki N, Phung Q, Chan S et al (2007) DUBA: A deubiquitinase that regulates type I interferon production. Science 318:1628-1632.
21. Komuro A, Horvath CM (2006) RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J Virol 80:12332-12342.
22. Li X, Lu C, Stewart M et al (2009) Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch Biochem Biophys 488:23-33.
23. Lin R, Lacoste J, Nakhaei P et al (2006a) Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80:6072-6083.
24. Lin R, Yang L, Nakhaei P et al (2006b) Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 281: 2095-2103.
25. Loo YM, Owen DM, Li K et al (2006) Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci USA 103:6001-6006.
26. Loo YM, Fornek J, Crochet N et al (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335-345.
27. Meylan E, Curran J, Hofmann K et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
28. Michallet MC, Meylan E, Ermolaeva MA et al (2008) TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28:651-661.
29. Moore CB, Bergstralh DT, Duncan JA et al (2008) NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451:573-577.
30. Oganesyan G, Saha SK, Guo B et al (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208-211.
31. Oshiumi H, Matsumoto M, Hatakeyama S et al (2009) Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 284:807-817.
32. Pichlmair A, Schulz O, Tan CP et al (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314:997-1001.
33. Pippig DA, Hellmuth JC, Cui S et al (2009) The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res 37:2014-2025.
34. Rothenfusser S, Goutagny N, DiPerna G et al (2005) The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175:5260-5268.
35. Saha SK, Pietras EM, He JQ et al (2006) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25:3257-3263.
36. Saito T, Hirai R, Loo YM et al (2007) Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 104:582-587.
37. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778-809.
38. Schlee M, Roth A, Hornung V et al (2009) Recognition of 5’ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25-34.
39. Schmidt A, Schwerd T, Hamm W et al (2009) 5’-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 106:12067-12072.
40. Seth RB, Sun L, Ea CK et al (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
41. Sumpter R Jr., Loo YM, Foy E et al (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689-2699.
42. Tabara H, Yigit E, Siomi H et al (2002) The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans. Cell 109:861-871.
43. Takahasi K, Yoneyama M, Nishihori T et al (2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29:428-440.
44. Tal MC, Sasai M, Lee HK et al (2009) Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A 106:2770-2775.
45. Theofilopoulos AN, Baccala R, Beutler B et al (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-336.
46. Uze G, Monneron D (2007) IL-28 and IL-29: Newcomers to the interferon family. Biochimie 89: 729-734.
47. Venkataraman T, Valdes M, Elsby R et al (2007) Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 178:6444-6455.
48. Wang Y, Zhang HX, Sun YP et al (2007) Rig-I-/- mice develop colitis associated with downregu-lation of G alpha i2. Cell Res 17:858-868.
49. Wang F, Gao X, Barrett JW et al (2008) RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog 4:e1000099.
50. Xu LG, Wang YY, Han KJ et al (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727-740.
51. Yasukawa K, Oshiumi H, Takeda M et al (2009) Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal 2:47.
52. Yoneyama M, Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227:54-65.
53. Yoneyama M, Kikuchi M, Natsukawa T et al (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737.
54. Yoneyama M, Kikuchi M, Matsumoto K et al (2005) Shared and unique functions of the DExD/H-Box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851-2858.
55. Yoshida R, Takaesu G, Yoshida H et al (2008) TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J Biol Chem 283:36211-36220.
56. Zhang M, Wu X, Lee AJ et al (2008) Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 283:18621-18626.
57. Zhong B, Yang Y, Li S et al (2008) The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-550.